[CME Group Q3 2026 Earnings Call] CME Posts Record Q3 Revenue of $1.7B, ADV Jumps 16% to 29.4M Contracts as Q4 Tracking 17% Above Record
CME Group reported record Q3 2026 revenue of $1.7B, up 13%, with average daily volume rising 16% to 29.4M contracts. All asset classes saw double-digit growth, and international participation hit a record 9M contracts. The company expects Q4 to be 17% above record levels, driven by strong market demand and product innovation.
How this was made
The 30-second read
Why it matters
The earnings beat and record metrics suggest a bullish short-term catalyst for CME stock.
Market read
CME's strong earnings may influence trading volumes and sentiment across the broader financial services sector.
What to watch
Regulatory delays on compute futures and 24/7 oil contracts could temper upside.
Background
CME Group's Q3 2026 earnings call highlighted record revenue, ADV, and new product launches.
Ticker impact
CME Group reported record Q3 2026 revenue of $1.7B and 16% ADV growth, a primary earnings disclosure.
upward pressure as investors price in record revenue and profit growth
Record financials and guidance indicate robust demand across all asset classes, suggesting continued buying interest.
Market effects
Positive outlook for exchange operators and market data providers; may lift peers in the trading infrastructure space.
U.S. markets may see a modest boost in financials and technology sectors.
CME's international ADV growth signals strength in global derivatives markets.
Counterpoint
If the market had already priced in strong growth, the earnings surprise may be muted.
Key entities
- CompanyCME Group
Leading derivatives exchange operator.
- ExecutiveTerry Duffy
Chairman and CEO of CME Group.



